Enanta Pharmaceuticals (ENTA) Asset Utilization Ratio (2013 - 2026)

Enanta Pharmaceuticals has reported Asset Utilization Ratio for 14 years, with the latest figure at 0.21 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 11.94% year-over-year to 0.21; the trailing twelve-month figure through Mar 2026 stood at 0.21 (up 11.94% YoY), and the FY2025 full-year result was 0.2, up 23.26% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.21, down from 0.22 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.24 in Q1 2023, with the low at 0.17 in Q4 2023.
• Historically, Asset Utilization Ratio has averaged 0.2 across 5 years, with a median of 0.21 in 2025.
• Annual changes were most pronounced in 2024 — Asset Utilization Ratio retreated 28.14% — and 2025, when it increased 28.74%.
• Enanta Pharmaceuticals' Asset Utilization Ratio stood at 0.23 in 2022, then slipped by 27.22% to 0.17 in 2023, then rose by 11.09% to 0.18 in 2024, then increased by 19.55% to 0.22 in 2025, then declined by 2.12% to 0.21 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.21 (Q1 2026), 0.22 (Q4 2025), and 0.22 (Q3 2025), per Business Quant data.